Delivering the Right Care, at the Right Time and Place: Renown Health Opens “Care Traffic Control Center”

NEXT STORY
Icosavax Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
PREV STORY
Mitch Gould of Nutritional Products International: U.S. Businesses in Better Shape to Adapt to Delta Variant
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sandoz receives European Commission approval for biosimilar Hyrimoz® (adalimumab)

Biosimilar Hyrimoz® (adalimumab) approved for use in all same indications as reference medicine*** including ...

author_avatar
NASDAQ Market News

Insmed to Present at Two October Conferences

BRIDGEWATER, N.J., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical ...

author_avatar
NASDAQ Market News

Novartis presents new data demonstrating long-term efficacy, safety and tolerability of Aimovig® (erenumab) in patients with chronic and episodic migraine

Results from a one-year study of efficacy and safety of Aimovig in chronic migraine ...

author_avatar
NASDAQ Market News